The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...
The intravenous formulation of fosfomycin has a novel mechanism of action an no known cross-resistance to other antibiotic ...
The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...
The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot ...
Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...
Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...
Ironwood Pharmaceuticals (IRWD) stock gains as the FDA approves a label expansion for the company's AbbVie (ABBV)-partnered ...
The Food and Drug Administration has approved a new non-hormonal pill to treat hot flashes and night sweats brought on by ...
The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday. The drug, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results